Aigen Investment Management, LP
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1741224
NEW YORK, NY
Position in BIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$449,902
-$212,935 QoQ
Shares Held
1,614
-33.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $10,476,105 across 13 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
49,551 | $4,496,257 | |
| 2 | MDT |
Medtronic plc
|
24,962 | $1,952,777 | |
| 3 | EW |
Edwards Lifesciences Corp
|
16,910 | $1,529,678 | |
| 4 | BSX |
Boston Scientific Corp
|
26,161 | $1,116,551 | |
| 5 | PODD |
Insulet Corp
|
3,046 | $463,753 | |
| 6 | HAE |
Haemonetics Corp
|
3,685 | $276,375 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
3,821 | $253,790 | |
| 8 | QTRX |
Quanterix Corp
|
24,328 | $105,096 |
All Filings in BIO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $449,902 | 1,614 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $662,837 | 2,427 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $233,462 | 675 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $364,542 | 1,129 | Shares | Sole | 2024-02-09 | |
| 2022-12-31 | $1,143,312 | 2,719 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $297,420 | 713 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $235,620 | 476 | Shares | Sole | 2022-08-02 | |
| No filing history on record for this holder in this stock. | ||||||